Provided by Tiger Trade Technology Pte. Ltd.

Regeneron Pharmaceuticals

794.19
-13.5200-1.67%
Pre-market: 815.5021.31+2.68%04:01 EDT
Volume:488.31K
Turnover:387.71M
Market Cap:81.77B
PE:19.64
High:809.40
Open:809.40
Low:789.08
Close:807.71
52wk High:847.00
52wk Low:541.00
Shares:102.95M
Float Shares:98.88M
Volume Ratio:0.74
T/O Rate:0.49%
Dividend:3.64
Dividend Rate:0.46%
EPS(TTM):40.43
EPS(LYR):41.48
ROE:14.04%
ROA:6.53%
PB:2.58
PE(LYR):19.15

Loading ...

Intellia Q2 FY26 Net Loss Widens to $106.63 Million; Revenue Falls to $7.66 Million

Reuters
·
Aug 06

Regeneron Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Aug 06

Wall Street Warms to Healthcare Stocks as Tech Trade Faces Turbulence

Reuters
·
Aug 05

Does Regeneron (REGN) Prioritize Shareholder Returns Over Earnings Quality As Profit Slips Amid Rising Sales?

Simply Wall St.
·
Aug 04

Fujian Haixi Pharma Wins FDA IND Clearance for Hx9428 Phase II nAMD Trial

Reuters
·
Aug 04

Regeneron Pharma is Maintained at Buy by Guggenheim

Dow Jones
·
Aug 03

Achieve Life Sciences Names Ronald Dadino SVP of CMC and Supply Chain

Reuters
·
Aug 03

Regeneron Pharmaceuticals (REGN) Posts Strong Q2 Revenue, Is The Upside Already Priced In?

Simply Wall St.
·
Aug 03

Regeneron price target raised to $740 from $700 at Citi

TIPRANKS
·
Aug 03

Biocon Launches Yesafili Biosimilar to Regeneron’s Eylea in US

Reuters
·
Aug 03

Weekly Winners | Microsoft Rockets 22%; Garmin Soars 21%; Amazon, Chipotle Jump 17% Each; Regeneron Pharmaceuticals Gains 16%

Tiger Newspress
·
Aug 02

Movement Alert|Regeneron Pharmaceuticals Rises 3.09% in Regular Trading, Q2 Earnings Beat Continues to Drive Stock Higher

Market Focus
·
Aug 01

Regeneron Announces Q3 2026 Distribution of R$ 0.05 Per Unit

Reuters
·
Jul 31

Regeneron Pharmaceuticals' Robust Q2 Sales Amid Limited Spend Increases to Help Ramp H2 Margins, RBC Says

MT Newswires Live
·
Jul 31

Regeneron Pharma is Maintained at Buy by Truist Securities

Dow Jones
·
Jul 31

Analysts Offer Insights on Healthcare Companies: Neurocrine (NBIX), Regeneron (REGN) and PTC Therapeutics (PTCT)

TIPRANKS
·
Jul 31

Regeneron price target raised to $795 from $750 at Cantor Fitzgerald

TIPRANKS
·
Jul 31

AbbVie Beats Q2 Revenue, Adjusted EPS Estimates but Cuts FY Adj EPS Guidance

Reuters
·
Jul 31

Moderna Posts Smaller-than-expected Q2 Loss Per Share on Lower R&D Spending

Reuters
·
Jul 31

Regeneron Awards $150,000 to Winners of the 2026 Regeneron Prize for Creative Innovation

GlobeNewswire
·
Jul 31